329 related articles for article (PubMed ID: 21641694)
41. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R
Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772
[TBL] [Abstract][Full Text] [Related]
42. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives.
Trávnícek Z; Szucová L; Popa I
J Inorg Biochem; 2007 Mar; 101(3):477-92. PubMed ID: 17208304
[TBL] [Abstract][Full Text] [Related]
43. Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles.
Zhu XK; Guan J; Tachibana Y; Bastow KF; Cho SJ; Cheng HH; Cheng YC; Gurwith M; Lee KH
J Med Chem; 1999 Jul; 42(13):2441-6. PubMed ID: 10395485
[TBL] [Abstract][Full Text] [Related]
44. Benzimidazole clubbed with triazolo-thiadiazoles and triazolo-thiadiazines: new anticancer agents.
Husain A; Rashid M; Shaharyar M; Siddiqui AA; Mishra R
Eur J Med Chem; 2013 Apr; 62():785-98. PubMed ID: 23333063
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-aryl-substituted 2-bis-1H-benzimidazoles.
Singh M; Tandon V
Eur J Med Chem; 2011 Feb; 46(2):659-69. PubMed ID: 21186067
[TBL] [Abstract][Full Text] [Related]
46. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
47. Biological activity of bis-benzimidazole derivatives on DNA topoisomerase I and HeLa, MCF7 and A431 cells.
Alpan AS; Zencir S; Zupkó I; Coban G; Réthy B; Gunes HS; Topcu Z
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):844-9. PubMed ID: 18951286
[TBL] [Abstract][Full Text] [Related]
48. Synthesis of functionalized amino acid derivatives as new pharmacophores for designing anticancer agents.
Kumar V; Mudgal MM; Rani N; Jha A; Jaggi M; Singh AT; Sanna VK; Singh P; Sharma PK; Irchhaiya R; Burman AC
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):763-70. PubMed ID: 18720190
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells.
Xia Y; Dong ZW; Zhao BX; Ge X; Meng N; Shin DS; Miao JY
Bioorg Med Chem; 2007 Nov; 15(22):6893-9. PubMed ID: 17804244
[TBL] [Abstract][Full Text] [Related]
50. Synthesis of novel 2, 5-dihydrofuran derivatives and evaluation of their anticancer activity.
Zhang Y; Zhong H; Wang T; Geng D; Zhang M; Li K
Eur J Med Chem; 2012 Feb; 48():69-80. PubMed ID: 22182926
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and cytotoxic evaluation of some new phthalazinylpiperazine derivatives.
Liu Y; Zhang S; Li Y; Wang J; Song Y; Gong P
Arch Pharm (Weinheim); 2012 Apr; 345(4):287-93. PubMed ID: 22006840
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and biological evaluation of ursolic acid-triazolyl derivatives as potential anti-cancer agents.
Rashid S; Dar BA; Majeed R; Hamid A; Bhat BA
Eur J Med Chem; 2013 Aug; 66():238-45. PubMed ID: 23811086
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and preliminary biological evaluation of novel taspine derivatives as anticancer agents.
Zhang J; Zhang Y; Shan Y; Li N; Ma W; He L
Eur J Med Chem; 2010 Jul; 45(7):2798-805. PubMed ID: 20304537
[TBL] [Abstract][Full Text] [Related]
54. Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2'-pyridyl)benzimidazole as ligand: comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives.
Serratrice M; Cinellu MA; Maiore L; Pilo M; Zucca A; Gabbiani C; Guerri A; Landini I; Nobili S; Mini E; Messori L
Inorg Chem; 2012 Mar; 51(5):3161-71. PubMed ID: 22339487
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and antitumor activity of novel benzimidazole-5-carboxylic acid derivatives and their transition metal complexes as topoisomerease II inhibitors.
Galal SA; Hegab KH; Hashem AM; Youssef NS
Eur J Med Chem; 2010 Dec; 45(12):5685-91. PubMed ID: 20884089
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and cytotoxicity of 3,4-disubstituted-5-(3,4,5-trimethoxyphenyl)-4H-1,2,4-triazoles and novel 5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives bearing 3,4,5-trimethoxyphenyl moiety.
Zhao PL; Duan AN; Zou M; Yang HK; You WW; Wu SG
Bioorg Med Chem Lett; 2012 Jul; 22(13):4471-4. PubMed ID: 22647723
[TBL] [Abstract][Full Text] [Related]
57. Quinazoline-tyrphostin as a new class of antitumor agents, molecular properties prediction, synthesis and biological testing.
Alafeefy AM; Alqasoumi SI; Ashour AE; Masand V; Al-Jaber NA; Ben Hadda T; Mohamed MA
Eur J Med Chem; 2012 Jul; 53():133-40. PubMed ID: 22520152
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and biological evaluation of novel steroidal[17,16-d][1,2,4]triazolo[1,5-a]pyrimidines.
Huang LH; Zheng YF; Lu YZ; Song CJ; Wang YG; Yu B; Liu HM
Steroids; 2012 May; 77(6):710-5. PubMed ID: 22445685
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and anticancer activity evaluation of a series of [1,2,4]triazolo[1,5-a]pyridinylpyridines in vitro and in vivo.
Wang XM; Xu J; Li YP; Li H; Jiang CS; Yang GD; Lu SM; Zhang SQ
Eur J Med Chem; 2013 Sep; 67():243-51. PubMed ID: 23871904
[TBL] [Abstract][Full Text] [Related]
60. Synthesis of substituted benzimidazolyl curcumin mimics and their anticancer activity.
Woo HB; Eom YW; Park KS; Ham J; Ahn CM; Lee S
Bioorg Med Chem Lett; 2012 Jan; 22(2):933-6. PubMed ID: 22222040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]